Viemed Healthcare, Inc.
VMD
$6.89
$0.385.84%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 16.87% | 19.62% | 17.41% | 26.91% | 27.90% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 16.87% | 19.62% | 17.41% | 26.91% | 27.90% |
| Cost of Revenue | 24.33% | 31.83% | 25.44% | 28.29% | 33.69% |
| Gross Profit | 11.67% | 12.54% | 12.46% | 25.99% | 24.15% |
| SG&A Expenses | 17.28% | 17.11% | 13.80% | 27.17% | 23.56% |
| Depreciation & Amortization | -16.14% | -20.97% | -16.95% | 26.51% | 72.92% |
| Other Operating Expenses | -188.46% | -438.46% | -573.17% | -16,750.00% | 67.90% |
| Total Operating Expenses | 19.77% | 22.65% | 18.09% | 26.30% | 27.69% |
| Operating Income | -38.35% | -4.68% | 10.94% | 34.70% | 32.17% |
| Income Before Tax | 72.65% | 24.21% | 29.72% | -26.59% | 5.10% |
| Income Tax Expenses | 83.78% | 17.64% | 20.76% | 5.49% | 3.39% |
| Earnings from Continuing Operations | 69.06% | 27.24% | 33.78% | -36.61% | 5.67% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 63.76% | 24.13% | 32.85% | -37.00% | 5.67% |
| EBIT | -38.35% | -4.68% | 10.94% | 34.70% | 32.17% |
| EBITDA | -7.27% | 1.59% | 8.87% | 26.24% | 32.03% |
| EPS Basic | 60.87% | 22.48% | 31.49% | -37.83% | 4.02% |
| Normalized Basic EPS | -50.13% | -8.09% | 5.37% | -15.20% | 20.80% |
| EPS Diluted | 50.00% | 35.79% | 42.57% | -37.00% | 0.50% |
| Normalized Diluted EPS | -50.27% | -9.32% | 5.51% | -13.75% | 20.51% |
| Average Basic Shares Outstanding | 1.83% | 1.39% | 1.13% | 1.30% | 1.47% |
| Average Diluted Shares Outstanding | 2.58% | 2.82% | 0.89% | -0.30% | 1.41% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |